Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Siegal, D. Eilbott, H. Burger, K. Gehan, B. Davidson, A. Kaell, B. Weiser (1990)
Dose‐limiting toxicity of rifabutin in AIDS‐related complex: syndrome of arthralgia/arthritisAIDS, 4
To the Editor: We report the occurrence of uveitis and pseudojaundice in patients with AIDS who were receiving the combination of clarithromycin, rifabutin, and ethambutol for the treatment of Mycobacterium avium complex bacteremia. We are conducting a prospective, randomized, multicenter study comparing two oral multidrug regimens for the treatment of M. avium complex bacteremia in adults with AIDS. As of November 5, 1993, 119 patients had entered this study, 59 of whom were assigned to receive a regimen consisting of 1000 mg of clarithromycin twice daily, 600 mg of rifabutin daily, and 15 mg of ethambutol per kilogram of body . . .
The New England Journal of Medicine – The New England Journal of Medicine
Published: Feb 10, 1994
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.